|
|
Volumn 370, Issue 9597, 2007, Pages 1479-1480
|
|
New treatments for age-related macular degeneration
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
PEGAPTANIB;
RANIBIZUMAB;
VASCULOTROPIN;
VASCULOTROPIN A;
ANGIOGENESIS INHIBITOR;
APTAMER;
MONOCLONAL ANTIBODY;
CONCENTRATION RESPONSE;
DIABETIC RETINOPATHY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LETTER;
NEOVASCULARIZATION (PATHOLOGY);
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
RISK BENEFIT ANALYSIS;
BLOOD;
DOSE RESPONSE;
DRUG ANTAGONISM;
NOTE;
RETINA MACULA DEGENERATION;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
APTAMERS, NUCLEOTIDE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MACULAR DEGENERATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 35448940430
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(07)61625-0 Document Type: Letter |
|
Times cited : (6)
|
|
References (3)
|
